Using the expanded list of genetic risk alleles as an instrument for identifying β2M, we conducted further bidirectional two-sample MR (TSMR) analyses between β2M and B-cell malignancies (DLBCL, FL, HL, CLL, and MM). The gene discussed is B2M; the disease is B-cell chronic lymphocytic leukemia.